STEVEN G. LITCHFIELD - 03 Feb 2023 Form 4 Insider Report for MAXLINEAR, INC (MXL)

Role
Chief Financial Officer and Chief Corporate Strategy Officer
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Issuer symbol
MXL
Transactions as of
03 Feb 2023
Transactions value $
$0
Form type
4
Filing time
07 Feb 2023, 20:45:45 UTC
Previous filing
03 Feb 2023
Next filing
23 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Award $0 +10.1K +5.23% $0.00 204K 03 Feb 2023 Direct F1
transaction MXL Common Stock Award $0 +78.1K +38.26% $0.00 282K 03 Feb 2023 Direct F2
transaction MXL Common Stock Award $0 +52.1K +18.45% $0.00 334K 03 Feb 2023 Direct F2
transaction MXL Common Stock Award $0 +11.9K +3.55% $0.00 346K 03 Feb 2023 Direct F3
transaction MXL Common Stock Award $0 +7.92K +2.29% $0.00 354K 03 Feb 2023 Direct F3
transaction MXL Common Stock Award $0 +3.5K +0.99% $0.00 358K 03 Feb 2023 Direct F4
transaction MXL Common Stock Award $0 +2.34K +0.65% $0.00 360K 03 Feb 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued to the Reporting Person for the 2022 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 3, 2023. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
F2 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
F3 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
F4 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on January 3, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.

Remarks:

Chief Financial Officer and Chief Corporate Strategy Officer